Anavo Therapeutics

About:

Anavo Therapeutics provides therapeutic potential of human phosphatase biology.

Website: https://www.anavotx.com/

Twitter/X: Anavo_Tx

Top Investors: MRL Ventures Fund, Bioqube Ventures, Inkef, M Ventures, Taiho Ventures

Description:

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications